SCHEMBL31504437

SCHEMBL31504437

O=C(NCCC1CCCCC1)c1cncc(Nc2ccc(OCc3ccccn3)cc2C2CC2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM4 P08173 1/20 0.40
▸ HPGD P15428 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ BRD4 O60885 1/20 0.37
▸ PDE10A Q9Y233 2/20 0.36
▸ RECQL P46063 1/20 0.36
▸ ALOX5 P09917 1/20 0.36
▸ PRMT3 O60678 1/20 0.36
▸ CNR2 P34972 1/20 0.36
▸ ITGB3 P05106 1/20 0.36
▸ ITGA2B P08514 1/20 0.36
▸ LDLR P01130 1/20 0.36
▸ RHOA P61586 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ KIT P10721 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21617270 1.00 CHRM4 (0.40) CHRM4HPGDMEN1KMT2ABRD4
SCHEMBL31504358 0.91 HPGD (0.40) CHRM4HPGDMEN1KMT2ABRD4
SCHEMBL21617185 0.91 HPGD (0.40) CHRM4HPGDMEN1KMT2ABRD4
SCHEMBL21617246 0.90 BRD4 (0.40) CHRM4HPGDMEN1KMT2ABRD4
SCHEMBL31504340 0.90 BRD4 (0.40) CHRM4HPGDMEN1KMT2ABRD4
SCHEMBL21617175 0.86 HPGD (0.40) CHRM4HPGDMEN1KMT2ABRD4
SCHEMBL31504436 0.86 HPGD (0.40) HPGDMEN1KMT2ARECQLALOX5
SCHEMBL21617228 0.86 HPGD (0.40) HPGDMEN1KMT2ARECQLALOX5
SCHEMBL31504337 0.86 HPGD (0.40) CHRM4HPGDMEN1KMT2ABRD4
SCHEMBL21617169 0.83 PRMT3 (0.45) HPGDMEN1KMT2APRMT3RHOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112638877-B Phenyl/pyridinyl-N-phenyl/pyridinyl derivatives for the treatment of RNA viral infections ABIVAX公司 2025-04-22 — — CN disclosed
Send feedback